Partners & News

Featured Updates

  • Intraperitoneal administration of cabazitaxel-loaded nanoparticles in peritoneal metastasis models

    February 27, 2023

    Intraperitoneal administration of cabazitaxel-loaded nanoparticles in peritoneal metastasis models

    Read the full publication here What you’ll learn in this article: PACA drug encapsulation improves treatment response in peritoneal metastases models. Intraperitoneal injection of PACA nanoparticles provides a beneficial drug biodistribution. Drug encapsulation in PACA nanoparticles improves intraperitoneal drug retention. The taxane cabazitaxel is a promising chemotherapy option for peritoneal metastases. Abstract: Colorectal and ovarian [...]

NaDeNo Collaborates With Leading Organizations

A selection of partners across the healthcare and research ecosystem

Innovation & Testing

Organizations that contribute to preclinical research, early testing, and technology development.

Clinical Development

Renowned clinical institutions driving patient-focused trials to validate efficacy and safety in real-world settings.

Manufacturing & Supply Chain

Partners enabling production, scalability, and raw material sourcing.

Funding & Ecosystems

Organizations providing financial support, innovation clusters, and strategic networks.

Latest Updates

  • NaDeNo referenced in Norwegian Scitech News — Combating severe cancer with a new drug delivery system

    January 31, 2023

    NaDeNo referenced in Norwegian Scitech News — Combating severe cancer with a new drug delivery system

    Reda the full article here Peritoneal cancer is difficult to treat and has a poor survival prognosis. But a new and effective nanomedicine delivery system is offering some hope. The company is called NaDeNo and is well underway with the development of a new cure for cancers that have spread to the peritoneal cavity. It [...]

  • Combating severe cancer with a new drug delivery system

    February 28, 2021

    Combating severe cancer with a new drug delivery system

    Peritoneal cancer is difficult to treat and has a poor survival prognosis. But a new and effective nanomedicine delivery system is offering some hope. The company is called NaDeNo and is well underway with the development of a new cure for cancers that have spread to the peritoneal cavity. It is a spin-off from SINTEF, [...]

  • Combating severe cancer with a new drug delivery system

    February 22, 2021

    Combating severe cancer with a new drug delivery system

    Peritoneal cancer is difficult to treat and has a poor survival prognosis. But a new and effective nanomedicine delivery system is offering some hope. The company is called NaDeNo and is well underway with the development of a new cure for cancers that have spread to the peritoneal cavity. It is a spin-off from SINTEF, [...]